Operational revenue stood at Rs 2,414 million, while EBITDA rose by 35.7 per cent to Rs 497 million, with margins climbing to 20.6 per cent from 16.3 per cent in Q2 FY24
Read More
In addition to revenue growth, HCG demonstrated robust gains across key financial indicators. For Q2, the company reported an adjusted EBITDA of Rs 1,042 million, marking a 21 per cent year-on-year increase with an EBITDA margin of 18.8 per cent
Read More
Glenmark reported consolidated revenue from operations of Rs. 32,442 million, marking a year-on-year (YoY) growth of 6.9 per cent from Rs. 30,361 million in the same period last year
Read More
The company informed that its revenue reached Rs. 2,859 crores, reflecting a 10 per cent increase compared to the same period last year
Read More
Focusing sharply on its core business resulted in a 68 per cent compound annual growth rate (CAGR), reducing adjusted negative EBITDA from Rs 162 crore to Rs 17 crore
Read More
For the annual performance in FY24, HCG's revenue was Rs 19,121 million
Read More
For the fiscal year 2023-24, Indegene witnessed a 12.3 per cent year-on-year (YoY) growth in revenue, reaching Rs 25,896 million
Read More
On an yearly basis, gross profit for FY24 was Rs16,291 million, up 22 per cent from Rs 13,328 million in FY23
Read More
